{"id":3588,"date":"2024-11-08T08:21:03","date_gmt":"2024-11-08T08:21:03","guid":{"rendered":"https:\/\/c-techlabs.com\/intl\/?p=3588"},"modified":"2026-03-31T17:04:01","modified_gmt":"2026-03-31T10:04:01","slug":"positive-electrostatic-therapy-for-metastatic-tumors-targeted-induction-of-apoptosis-in-cancer-cells-using-pure-electric-charges-cancer-medicine","status":"publish","type":"post","link":"https:\/\/c-techlabs.com\/intl\/positive-electrostatic-therapy-for-metastatic-tumors-targeted-induction-of-apoptosis-in-cancer-cells-using-pure-electric-charges-cancer-medicine\/","title":{"rendered":"Positive Electrostatic Therapy for Metastatic Tumors: Targeted Induction of Apoptosis in Cancer Cells Using Pure Electric Charges (Cancer Medicine)"},"content":{"rendered":"<h4 class=\"font_8 wixui-rich-text__text\"><span class=\"wixui-rich-text__text\">Key Findings:<\/span><\/h4>\n<ol>\n<li><span class=\"wixui-rich-text__text\"><strong>Selective Apoptosis:<\/strong><\/span>\n<ul>\n<li><span class=\"wixui-rich-text__text\">The study demonstrated that Positive Electrostatic Charges (PECs) could selectively induce apoptosis in breast cancer cell lines, including MCF-7 (hormone receptor-positive breast cancer) and MDA-MB-468 (triple-negative breast cancer) cells. The therapy showed significant reductions in cell viability, while normal breast epithelial cells (MCF-10A) were not adversely affected, highlighting the selectivity of PECs.<\/span><\/li>\n<\/ul>\n<\/li>\n<li><span class=\"wixui-rich-text__text\"><strong>Mechanism of Action:<\/strong><\/span>\n<ul>\n<li><span class=\"wixui-rich-text__text\">PECs were found to disrupt the cytoskeleton and critical metabolic pathways in cancer cells, leading to apoptosis. This effect was particularly noted in MCF-7 cells, where PECs caused disruptions in the cell cycle and induced apoptosis through the mitochondrial pathway, evidenced by changes in the expression of apoptosis-related proteins.\u00a0<\/span><\/li>\n<li class=\"font_8 wixui-rich-text__text\"><span class=\"wixui-rich-text__text\">\u200b<\/span><span class=\"wixui-rich-text__text\">MCF-10A Control: The lack of similar disruptions in MCF-10A cells underscores the\u00a0<\/span><span class=\"wixui-rich-text__text\">specificity of PECs for malignant cells, making it a promising therapeutic approach\u00a0<\/span><span class=\"wixui-rich-text__text\">with minimal risk to normal tissues.<\/span><\/li>\n<\/ul>\n<\/li>\n<li><span class=\"wixui-rich-text__text\"><strong>In Vivo Validation:<\/strong><\/span>\n<ul>\n<li class=\"font_8 wixui-rich-text__text\"><span class=\"wixui-rich-text__text\">The study extended these findings to animal models, where tumors derived from\u00a0MCF-7 cells were treated with PECs. Significant tumor reduction was observed in the\u00a0treated animals, with no adverse effects on surrounding normal tissues, indicating\u00a0that PECs could effectively target tumors without collateral damage.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<h4><span class=\"wixui-rich-text__text\">Clinical Impact:<\/span><\/h4>\n<ol>\n<li><strong><span class=\"wixui-rich-text__text\">Non-Invasive Cancer Treatment:<\/span><\/strong>\n<ul>\n<li><span class=\"wixui-rich-text__text\">PEC therapy offers a promising non-invasive treatment option for breast cancer,\u00a0particularly for patients with tumors that are resistant to standard therapies. The\u00a0ability to selectively target cancer cells like MCF-7 while sparing normal cells such as MCF-10A could lead to fewer side effects and better overall patient outcomes.<\/span><\/li>\n<\/ul>\n<\/li>\n<li><strong><span class=\"wixui-rich-text__text\">Potential for Metastatic and Hormone-Responsive Breast Cancer:<\/span><\/strong>\n<ul>\n<li><span class=\"wixui-rich-text__text\">Given the effectiveness of PECs in targeting both MCF-7 (hormone receptor-positive)\u00a0and MDA-MB-468 (triple-negative) breast cancer cells, this therapy could be applied\u00a0to a broad spectrum of breast cancer subtypes, including those that are metastatic or hormone-responsive.<\/span><\/li>\n<\/ul>\n<\/li>\n<li><strong><span class=\"wixui-rich-text__text\">Foundation for Human Trials:<\/span><\/strong>\n<ul>\n<li><span class=\"wixui-rich-text__text\">The strong preclinical evidence, particularly the selectivity demonstrated in both\u00a0cancerous (MCF-7, MDA-MB-468) and non-cancerous (MCF-10A) cells, supports the\u00a0initiation of human trials. Successful human trials could lead to PEC being integrated\u00a0into treatment protocols for various types of breast cancer.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>Key Findings: Selective Apoptosis: The study demonstrated that Positive Electrostatic Charges (PECs) could selectively induce apoptosis in breast cancer cell lines, including MCF-7 (hormone receptor-positive breast cancer) and MDA-MB-468 (triple-negative breast cancer) cells. The therapy showed significant reductions in cell viability, while normal breast epithelial cells (MCF-10A) were not adversely affected, highlighting the selectivity of [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"advanced_seo_description":"","jetpack_seo_html_title":"","jetpack_seo_noindex":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[202,31],"tags":[],"class_list":["post-3588","post","type-post","status-publish","format-standard","hentry","category-in-vivo","category-research-articles"],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/c-techlabs.com\/intl\/wp-json\/wp\/v2\/posts\/3588","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/c-techlabs.com\/intl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/c-techlabs.com\/intl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/c-techlabs.com\/intl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/c-techlabs.com\/intl\/wp-json\/wp\/v2\/comments?post=3588"}],"version-history":[{"count":1,"href":"https:\/\/c-techlabs.com\/intl\/wp-json\/wp\/v2\/posts\/3588\/revisions"}],"predecessor-version":[{"id":5245,"href":"https:\/\/c-techlabs.com\/intl\/wp-json\/wp\/v2\/posts\/3588\/revisions\/5245"}],"wp:attachment":[{"href":"https:\/\/c-techlabs.com\/intl\/wp-json\/wp\/v2\/media?parent=3588"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/c-techlabs.com\/intl\/wp-json\/wp\/v2\/categories?post=3588"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/c-techlabs.com\/intl\/wp-json\/wp\/v2\/tags?post=3588"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}